Geron Corporation (GERN)

Currency in USD
1.2000
-0.0100(-0.83%)
Closed·
1.2085+0.0085(+0.71%)
·

GERN Earnings

Latest Release
Aug 05, 2026
EPS / Forecast
-0.02 / -0.01
Revenue / Forecast
57.48M / 55.21M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/09--/-0.008--/60.69M----Free Sign Up
2026/06-0.020/-0.01057.48M/55.21M-100%+4.11%Free Sign Up
2026/03-0.010/-0.02051.84M/50.11M+50%+3.45%Free Sign Up
2025/12-0.050/-0.03048.02M/50.76M-66.67%-5.4%Free Sign Up
2025/09-0.030/-0.03047.20M/54.49M0%-13.38%Free Sign Up
2025/06-0.020/-0.03049.04M/47.81M+33.33%+2.57%Free Sign Up
2025/03-0.030/-0.03039.60M/50.46M0%-21.52%Free Sign Up
2024/12-0.040/-0.03047.54M/61.93M-33.33%-23.24%Free Sign Up
2024/09-0.040/-0.08028.27M/18.92M+50%+49.42%Free Sign Up
2024/06-0.100/-0.103882.00K/344.80K+2.91%+155.8%Free Sign Up

All numbers in USD

Geron Corporation Earnings Call Summary for Q2/2026

  • Geron Q2 2026 revenue hit $57.48M, beating estimates by 4.11%; EPS loss of 2 cents missed forecast by 1 cent amid ongoing unprofitability.
  • RYTELO drug sales rose 17% YoY and 11% sequentially, driving revenue growth; company expects FY2026 revenue at mid-to-high end of $220M-$240M range.
  • Operating expenses fell 4% in H1 2026 despite 24% revenue growth, demonstrating improved cost discipline as commercialization strategy gains traction.
  • Shares slipped 0.11% to $1.3385 in premarket trading; company holds $327M in cash and securities with current ratio of 6.78 indicating strong liquidity.
  • Management plans to announce European commercialization strategy by year-end; phase 3 myelofibrosis trial continues on long-term timeline with no changes.
Last Updated: 2026-08-05, 08:46 a/m
Read Full Transcript

FAQ

What Is Geron's Earnings Per Share (TTM)?

The Geron EPS (TTM) is -0.1011.

When Is The Next Geron Earnings Date?

Geron will release its next earnings report on Nov 11, 2026.

What Is Geron’s Revenue Forecasts For Upcoming Quarters?

Geron’s revenue forecast is 60.69M.

How Did Geron React to the Company's Latest Earnings Report?

Geron reported a -100% EPS surprise and a +4.11% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by 17.1600%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.